[go: up one dir, main page]

MX2009009060A - Un metodo de identificacion de celulas que muestren sensibilidad a la modulacion de la señalizacion mediada por un receptor del factor de crecimiento de fibroplastos o una variante del mismo. - Google Patents

Un metodo de identificacion de celulas que muestren sensibilidad a la modulacion de la señalizacion mediada por un receptor del factor de crecimiento de fibroplastos o una variante del mismo.

Info

Publication number
MX2009009060A
MX2009009060A MX2009009060A MX2009009060A MX2009009060A MX 2009009060 A MX2009009060 A MX 2009009060A MX 2009009060 A MX2009009060 A MX 2009009060A MX 2009009060 A MX2009009060 A MX 2009009060A MX 2009009060 A MX2009009060 A MX 2009009060A
Authority
MX
Mexico
Prior art keywords
cells
growth factor
factor receptor
fibroblast growth
phosphorylation
Prior art date
Application number
MX2009009060A
Other languages
English (en)
Inventor
Carlos Garcia-Echeverria
Vito Guagnano
Diana Graus Porta
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009009060A publication Critical patent/MX2009009060A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G01N33/575—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se basa en el descubrimiento de que las células que muestran fosforilación (especialmente de tirosina) del sustrato del FGF-lR 2 (FRS-2), en contraste con las células que carecen de esta fosforilación, permiten hacer una predicción de que el tratamiento con un modulador, en especial con un inhibidor, de la señalización del receptor del factor de crecimiento de fibroblastos, tendrá éxito en las células, por ejemplo, a partir de muestras biológicas de pacientes que muestren esta fosforilación. Por consiguiente, la fosforilación del FRS-2 puede servir como un biomarcador de la posibilidad del tratamiento de éxito. La invención se refiere a diferentes métodos, usos, kits, y reactivos útiles en la aplicación de este biomarcador.
MX2009009060A 2007-02-27 2008-02-25 Un metodo de identificacion de celulas que muestren sensibilidad a la modulacion de la señalizacion mediada por un receptor del factor de crecimiento de fibroplastos o una variante del mismo. MX2009009060A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103094 2007-02-27
PCT/EP2008/052271 WO2008104523A1 (en) 2007-02-27 2008-02-25 A method of identification of cells that show sensitivity to modulation of signaling mediated by a fibroblast growth factor receptor or a variant thereof

Publications (1)

Publication Number Publication Date
MX2009009060A true MX2009009060A (es) 2009-08-31

Family

ID=38134144

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009060A MX2009009060A (es) 2007-02-27 2008-02-25 Un metodo de identificacion de celulas que muestren sensibilidad a la modulacion de la señalizacion mediada por un receptor del factor de crecimiento de fibroplastos o una variante del mismo.

Country Status (16)

Country Link
US (2) US20100075337A1 (es)
EP (1) EP2132574A1 (es)
JP (1) JP2010518869A (es)
KR (1) KR20090123870A (es)
CN (1) CN101632021A (es)
AU (1) AU2008220821B2 (es)
BR (1) BRPI0807696A2 (es)
CA (1) CA2677986A1 (es)
IL (1) IL200167A0 (es)
MA (1) MA31203B1 (es)
MX (1) MX2009009060A (es)
NZ (1) NZ578716A (es)
RU (1) RU2519223C2 (es)
TN (1) TN2009000348A1 (es)
WO (1) WO2008104523A1 (es)
ZA (1) ZA200905226B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102839867B1 (ko) 2014-09-26 2025-07-28 얀센 파마슈티카 엔브이 Fgfr 억제제를 사용한 치료에 반응할 암 환자를 확인하는 데 있어서 fgfr 돌연변이 유전자 패널의 사용
EP3256473A4 (en) 2015-02-12 2018-08-01 Memorial Sloan Kettering Cancer Center Synergistic cancer treatment
KR102071122B1 (ko) * 2015-05-14 2020-01-29 익스프레션 패톨로지, 인크. 섬유아세포 증식 인자 수용체 2(fgfr2) 단백질에 대한 srm/mrm 분석법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310181B1 (en) * 1996-12-03 2001-10-30 New York University Medical Center Adaptor protein FRS2 and related products and methods
EP1773305A2 (en) * 2004-05-25 2007-04-18 Yale University Corporation Method for treating skeletal disorders resulting from fgfr malfunction

Also Published As

Publication number Publication date
US20120315648A1 (en) 2012-12-13
EP2132574A1 (en) 2009-12-16
IL200167A0 (en) 2010-04-15
KR20090123870A (ko) 2009-12-02
RU2009135864A (ru) 2011-04-10
BRPI0807696A2 (pt) 2014-05-27
AU2008220821B2 (en) 2012-09-13
WO2008104523A1 (en) 2008-09-04
TN2009000348A1 (en) 2010-12-31
NZ578716A (en) 2012-02-24
CN101632021A (zh) 2010-01-20
RU2519223C2 (ru) 2014-06-10
US20100075337A1 (en) 2010-03-25
MA31203B1 (fr) 2010-02-01
JP2010518869A (ja) 2010-06-03
CA2677986A1 (en) 2008-09-04
ZA200905226B (en) 2010-04-28
AU2008220821A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
ECSP088171A (es) Metodo para la prediccion de la respuesta a un tratamiento
BRPI0612967B8 (pt) método para a determinação in vitro da atividade de trombina em uma amostra biológica e kit
ECSP17025787A (es) Uso de paneles de genes mutantes de fgfr en la identificación de pacientes con cáncer que responderán al tratamiento con un inhibidor de fgfr
ATE526333T1 (de) Reagentien zum nachweis von hypochloriger säure
ATE489482T1 (de) Verfahren zur herstellung von hybridsubstraten mit dna und antikörpern sowie verwendungen davon
Kim et al. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways
MX2013000996A (es) Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
ES2721440T3 (es) Nuevo método para inducir células precursoras neurales productoras de dopamina
Lim et al. Pulsed‐electromagnetic‐field‐assisted reduced graphene oxide substrates for multidifferentiation of human mesenchymal stem cells
NO20073487L (no) Valg av pasienter for terapi med en HER-inhibitor
MX2019006565A (es) Medio de cultivo para celulas madre epiteliales y organoides que comprenden las celulas madre.
AR080505A1 (es) Metodos para el tratamiento de linfoma no hodkin usando lenalidomida, y bimarcadores genicos y proteicos como indicadores
MX2008009592A (es) Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario.
PH12019502710A1 (en) Fgfr2 inhibitors for the treatment of cholangiocarcinoma
BR112012014925A2 (pt) compostos promotores de replicação de células beta e métodos de uso dos mesmos
ES2530734T3 (es) Biomarcador en suero bioquímico
ATE504836T1 (de) Verfahren zur identifizierung von trpv2- modulatoren
ES2530743T3 (es) Método in vitro y kit para el pronóstico o predicción de la respuesta por parte de pacientes con artritis reumatoide al tratamiento con agentes bloqueantes del factor TNFalfa
MX2025004103A (es) Metodos de identificacion de pacientes con posibilidad de beneficiarse de un tratamiento con un inhibidor de la telomerasa
MX2009009060A (es) Un metodo de identificacion de celulas que muestren sensibilidad a la modulacion de la señalizacion mediada por un receptor del factor de crecimiento de fibroplastos o una variante del mismo.
Mengqi et al. Micro/nano topography with altered nanotube diameter differentially trigger endoplasmic reticulum stress to mediate bone mesenchymal stem cell osteogenic differentiation
MX2019012169A (es) Ensayos para evaluar la actividad de moduladores de miembros de la familia de hidroxiesteroide (17-beta) deshidrogenasa (hsd17b).
Zhao et al. A novel quantitative angiogenesis assay based on visualized vascular organoid
CY1115062T1 (el) Μεθοδος μεμβρανικου προσδιορισμου
ES2662571T3 (es) Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration